Evidence map›Paper›PMID 34680745›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Mylene Vaillancourt, Sam P Limsuwannarot, Catherine Bresee, Rahgavi Poopalarajah, Peter Jorth

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. UnderstandingMicroorganisms · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Antibiotics (Basel, Switzerland) · 2024
    Review
  14. Review
  15. Adaptive response ofMicrobiology (Reading, England) · 2024
    Article
  16. bioRxiv : the preprint server for biology · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Mylene VaillancourtDepartment of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Sam P LimsuwannarotDepartment of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Catherine BreseeBiostatistics Core, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Rahgavi PoopalarajahDepartment of Biological Sciences, University of Calgary, Calgary, AB T2N 1N4, Canada.
Peter JorthDepartment of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.ORCID 0000-0002-0981-740X
Cedars-Sinai Medical Center · USUniversity of Calgary · CA

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Molecular mechanisms of hypervirulence in antibiotic-resistant Pseudomonas aeruginosaR01AI146425 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI JORTH, PETER ALLAN · 2020 to 2023
$2.3M
Determining mechanisms and prevalence of virulence-enhancing resistance mutationsK22AI127473 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI JORTH, PETER ALLAN · 2018 to 2019
$268k
Cystic Fibrosis Foundation JORTH17F5Cystic Fibrosis Foundation JORTH19P0NIAID NIH HHS K22 AI127473NIAID NIH HHS R01 AI146425NIH HHS K22AI127473NIH HHS R01AI146425NIH HHS UL1TR001881
6 · The paper itself

Abstract

Antibiotic-resistant

Indexed as

antibiotic resistancecystic fibrosisefflux pumpsevolutionPseudomonasvirulence

Identifiers

PMID34680745
PMCPMC8532662
OpenAlexW3202817459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.